Viewing Study NCT00427856


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2025-12-25 @ 9:26 PM
Study NCT ID: NCT00427856
Status: COMPLETED
Last Update Posted: 2016-07-22
First Post: 2007-01-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL)
Sponsor: Gemin X
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module